INTELLIGENT BIO SOLUTIONS INC. Foreign Currency Transaction Gain (Loss), before Tax
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Foreign Currency Transaction Gain (Loss), before Tax of -$3.10 thousand for the 6-month period ending 2021-12-31, per its 10-Q filed 2022-02-11.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2022-02-11
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), before tax for the quarter ending 2021-12-31 was $14.00.
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), before tax for the quarter ending 2021-09-30 was -$3.12K, a 100.55% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), before tax for the quarter ending 2021-06-30 was $892.00.
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), before tax for the quarter ending 2021-03-31 was -$262.03K.
- INTELLIGENT BIO SOLUTIONS INC. foreign currency transaction gain (loss), before tax for fiscal 2021 was $271.23K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2021-12-31 | $14.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | -$3.10K 10-Q · filed 2022-02-11 | -$2.21K derived: sum of 3 quarters · filed 2022-02-11 | -$264.24K derived: sum of 4 quarters · filed 2022-02-11 |
| 2021-09-30 | -$3.12K 10-Q · filed 2021-11-12 | -$2.23K derived: sum of 2 quarters · filed 2021-11-12 | -$264.26K derived: sum of 3 quarters · filed 2021-11-12 | -$298.11K derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $892.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | -$261.14K derived: sum of 2 quarters · filed 2021-09-16 | -$295.00K derived: sum of 3 quarters · filed 2021-09-16 | $271.23K 10-K · filed 2021-09-16 |
| 2021-03-31 | -$262.03K 10-Q · filed 2021-05-13 | -$295.89K derived: sum of 2 quarters · filed 2021-05-13 | $270.33K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$33.86K 10-Q · filed 2021-02-12 | $16.71K 10-Q · filed 2022-02-11 | ||
| 2020-09-30 | $566.22K derived: 10-K 12 month − 3 quarters · filed 2021-09-16 | |||
| 2020-03-31 | -$100.92K 10-Q · filed 2021-05-13 | $32.37K derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $133.29K 10-Q · filed 2021-02-12 | $129.05K 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |